-
Signature
-
Teresa Bair
-
Issuer symbol
-
KURA
-
Transactions as of
-
02 Jan 2026
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
06 Jan 2026, 16:30:04 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Bair Teresa Brophy |
Chief Legal Officer |
C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO |
Teresa Bair |
06 Jan 2026 |
0001813058 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
KURA |
Common Stock |
Award |
$0 |
+50,000 |
+27% |
$0.000000 |
238,139 |
02 Jan 2026 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
KURA |
Option to purchase common stock |
Award |
$0 |
+100,000 |
|
$0.000000 |
100,000 |
02 Jan 2026 |
Common Stock |
100,000 |
$10.34 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: